Minimal residual disease monitoring by flow cytometry
- 31 December 2003
- journal article
- Published by Elsevier in Best Practice & Research Clinical Haematology
- Vol. 16 (4) , 599-612
- https://doi.org/10.1016/s1521-6926(03)00067-7
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemiaBlood, 2002
- Minimal residual disease in leukaemia patientsThe Lancet Oncology, 2001
- High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)Blood, 2001
- Detection of minimal residual disease in acute leukemia by flow cytometryCytometry, 1999
- INVESTIGATION OF MINIMAL RESIDUAL DISEASE IN CHILDHOOD AND ADULT ACUTE LYMPHOBLASTIC LEUKAEMIA BY MOLECULAR ANALYSISBritish Journal of Haematology, 1999
- Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALLLeukemia, 1999
- Detection of abnormalities in B‐cell differentiation pattern is a useful tool to predict relapse in precursor‐B‐ALLBritish Journal of Haematology, 1999
- Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhoodThe Lancet, 1998
- Phenotypic changes in acute myeloid leukaemia: implications in the detection of minimal residual disease.Journal of Clinical Pathology, 1996
- Characterization of aberrant phenotypes in acute myeloblastic leukemiaAnnals of Hematology, 1995